Vitruvias Therapeutics Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
11
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
6
Vitruvias Therapeutics General Information
Description
Operator of a generic pharmaceutical company intended to develop complex APIs and finished dosage forms that are inherently difficult to manufacture. The company manufactures technically difficult generic products and overcomes the manufacturing complexities and raw material sourcing challenges by utilizing strategic partnerships in order to increase the availability of vital generic drugs.
Contact Information
Website
www.vitruvias.com(Operating Subsidiary)
Corporate Office
- 778 North Dean Road
- Suite 600
- Auburn, AL 36830
- United States
Corporate Office
- 778 North Dean Road
- Suite 600
- Auburn, AL 36830
- United States
Vitruvias Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Vitruvias Therapeutics Comparisons
Industry
Financing
Details
Vitruvias Therapeutics Competitors (8)
One of Vitruvias Therapeutics’s 8 competitors is Cipla, a Corporation company based in Mumbai, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cipla | Corporation | Mumbai, India | ||||
| Dr. Reddy's | Corporation | Hyderabad, India | ||||
| Pfizer (Vienna) | Corporation | Vienna, Austria | ||||
| GSK | Corporation | London, United Kingdom | ||||
| Novartis | Corporation | Basel, Switzerland |
Vitruvias Therapeutics Signals
Vitruvias Therapeutics Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Vitruvias Therapeutics FAQs
-
When was Vitruvias Therapeutics founded?
Vitruvias Therapeutics was founded in 2013.
-
Where is Vitruvias Therapeutics headquartered?
Vitruvias Therapeutics is headquartered in Auburn, AL.
-
What is the size of Vitruvias Therapeutics?
Vitruvias Therapeutics has 11 total employees.
-
What industry is Vitruvias Therapeutics in?
Vitruvias Therapeutics’s primary industry is Pharmaceuticals.
-
Is Vitruvias Therapeutics a private or public company?
Vitruvias Therapeutics is a Private company.
-
What is Vitruvias Therapeutics’s current revenue?
The current revenue for Vitruvias Therapeutics is .
-
How much funding has Vitruvias Therapeutics raised over time?
Vitruvias Therapeutics has raised $15M.
-
Who are Vitruvias Therapeutics’s investors?
JW Asset Management and Perceptive Advisors have invested in Vitruvias Therapeutics.
-
Who are Vitruvias Therapeutics’s competitors?
Cipla, Dr. Reddy's, Pfizer (Vienna), GSK, and Novartis are some of the 8 competitors of Vitruvias Therapeutics.
-
When was Vitruvias Therapeutics acquired?
Vitruvias Therapeutics was acquired on 06-Aug-2026.
-
Who acquired Vitruvias Therapeutics?
Vitruvias Therapeutics was acquired by H2 Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process